Skip to main content

What Is The Role of The Responsible Person in the Pharma Industry?

This brief explainer looks at the role of the Responsible Person (RP) in the pharmaceutical industry and highlights the role’s responsibilities.

The highly regulated pharmaceutical industry places strict requirements on the manufacturing, testing and distribution of medicinal products. Compliance with these regulations is essential to ensure that products are safe and effective for use in patients. One of the key roles in ensuring compliance with these regulations is that of the Responsible Person (RP) in the Good Distribution Practice (GDP) of medicinal products. This article looks at the role of the RP in the pharmaceutical industry and considers options for training your staff and making your facility GDP compliant.

What Is the Responsible Person?

The European GDP Association sums up the role of the RP as follows::

“The RP is responsible for safeguarding product users against potential hazards arising from poor distribution practices”

The RP is a key role in the Good Distribution Practice of medicinal products in the pharmaceutical industry. As per the European GDP Guideline, the RP is responsible for safeguarding against potential hazards arising from poor distribution practices, ensuring that the provisions of the license are obeyed and maintaining an adequate quality system. The Responsible Person is required to have personal knowledge of the products traded under the license, appropriate competence and experience, and knowledge of and training in GDP.

The role of the Responsible Person starts at the point when a medicinal product is released for distribution by the manufacturer. The RP is responsible for ensuring that the product is transported, stored and delivered according to the license and in compliance with GDP regulations. In addition, the RP is responsible for ensuring that the product is not tampered with, stolen or counterfeited during distribution.

Responsibilities of the Responsible Person

The Responsible Person has several responsibilities, which include the following:

  1. Ensuring that the quality management system is in place and that it complies with GDP regulations.
  2. Ensuring that the products are transported, stored and delivered according to the license and in compliance with GDP regulations.
  3. Ensuring that the products are not tampered with, stolen or counterfeited during distribution.
  4. Ensuring that the products are properly labeled and that all necessary documentation is completed and maintained.
  5. Ensuring that any deviations from GDP regulations are identified, documented and investigated, and that corrective actions are taken to prevent a recurrence.
  6. Ensuring that all personnel involved in the distribution process are trained and competent in GDP regulations.
  7. Ensuring that all records related to the distribution process are complete, accurate and maintained.

The RP is responsible for ensuring that all medicinal products are distributed in a safe and compliant manner. Any failure to comply with GDP regulations can result in serious consequences, including product recalls, fines and reputational damage.

Training and Qualifications of the Responsible Person

The RP should have the appropriate competence and experience to fulfill their role. The RP should have personal knowledge of the products traded under the license and should be appropriately trained in GDP regulations. In addition, the RP should have the necessary skills to manage and lead the distribution team effectively.

NSF hosts regular training courses for ‘Responsible Person and Good Distribution Practice’. Our training is MHRA-recognized Cogent Gold Standard. Catherine Kay from NSF looks at the key challenges for the Responsible Person and explains the Cogent Gold Standard in a related article that you can read here.

The RP should have a relevant degree or an equivalent qualification. The RP should also have several years of experience in the pharmaceutical industry and experience in the distribution of medicinal products.

In addition to the traditional qualifications, the RP should have technical knowledge, including a good understanding of GDP regulations, pharmaceutical quality systems and supply chain management. Moreover, the RP should have behavioral skills, such as leadership and communication, to manage the distribution team effectively.

Conclusion

The role of the RP is critical to ensuring that medicinal products are distributed in a safe and compliant manner. The RP is responsible for ensuring that the quality management system complies with GDP regulations; that products are transported, stored and delivered safely; that deviations from GDP regulations are identified and investigated; and that all personnel involved in the distribution process are trained in GDP regulations. The correct training and qualifications of the RP are crucial to ensuring that they can fulfill their role effectively. Compliance with GDP regulations is essential to ensure that products are safe and effective for use in patients.

Don’t leave the safety of your medicinal products to chance. Contact us today to learn more about our RP training services and how we can help ensure that your products are distributed safely and effectively.

Ready To Begin the Process?

Contact us with questions or to receive a quote.

Pharma and Biotech Support

Our experts help pharmaceutical and biotech companies establish or remediate quality systems, mitigate risks and achieve sustainable compliance.
Learn more

How NSF Can Help You

Get in touch to find out how we can help you and your business thrive.

What’s New with NSF

  • iNADO Partners with NSF to Support Members and Athletes

    May 27, 2026
    iNADO is pleased to welcome NSF’s expertise and experience in support of its members and the athletes they serve
    Read the Story
  • NSF Ends UK’s Three-Year Testing Gap with REG 31 Testing Designation

    May 20, 2026
    NSF’s Oakdale laboratory becomes the UK’s sole facility offering comprehensive BS 6920 and REG 31 testing, closing a critical drinking water safety gap.
    Read the Story
  • Tangent® Materials Announces Industry First: Tangent PolySheet™ CB Earns Certification to NSF 537, Becoming the First PFAS-Free NSF Standard 51 Food Equipment Material

    May 20, 2026
    New food-grade synthetic cutting-board sheet, engineered from the ground up without per- and polyfluoroalkyl substances (PFAS), establishes a new materialsafety benchmark for food-contact and food-equipment applications.
    Read the Story
  • NSF Expands Food Equipment Portfolio with Electrical Safety Testing and Certification

    April 30, 2026
    Manufacturers now have a “one-stop-shop” for both sanitation and electrical safety certification, enabling market expansion and regulatory compliance.
    Read the Story